• 

  October 3, 2025

  NIH Launches Nation’s First Dedicated Organoid Development Center

  R.D. Solorzano

• 

  September 23, 2025

  Prellis Biologics and Eli Lilly Sign Multi-Target Antibody Discovery Agreement

  R.D. Solorzano

• 

  May 6, 2025

  Quris Technologies Demonstrates Liver-Driven Brain Toxicity in New Multi-Organ Model

  R.D. Solorzano

• 

  May 6, 2025

  VivoSim Labs Introduces NAMkind Platform for Human-Based Drug Testing Models

  R.D. Solorzano

• 

  April 27, 2025

  Vivodyne CEO Discusses FDA’s Move Away from Animal Testing and the Future of Humanized Drug Development

  R.D. Solorzano

• 

  April 3, 2025

  Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies

  R.D. Solorzano

• 

  September 3, 2024

  Carcinotech’s 3D-Printed Tumor Models: A New Possibility in Cancer Research

  R.D. Solorzano

• 

  September 7, 2023

  The way to make money in pharma with bioprinting?…Develop the drugs

  R.D. Solorzano